Leigh Hochberg, MD, PhD
Director, BrainGate Consortium and Clinical Trials
Director, Center for Neurotechnology and Neurorecovery, Neurocritical Care and Acute Stroke Services, Department of Neurology
Massachusetts General Hospital
L. Herbert Ballou University Professor of Engineering
Director, VA RR&D Center for Neurorestoration and Neurotechnology, Rehabilitation R&D Service
VA Providence Healthcare System
Senior Lecturer on Neurology
Harvard Medical School
Dr. Hochberg’s research focuses on the development and testing of novel neurotechnologies to help people with paralysis and other neurologic disorders, and on understanding cortical neuronal ensemble activities. As IDE Sponsor-Investigator, Principal Investigator and lead Clinical Investigator of the pilot clinical trials of the BrainGate2 Neural Interface System, he has been honored with the Joseph Martin Prize in Basic Research, the Herbert Pardes Prize for Excellence in Clinical Research, and the Derek Denny-Brown Young Neurological Scholar Award. He is a Fellow of the American Academy of Neurology and the American Neurological Association, and has received grant awards from the Doris Duke Charitable Foundation, the ALS Association, the American Heart Association, the Department of Veterans Affairs, and the National Institutes of Health (NIDCD and BRAIN Intitiative/NINDS).
Dr. Hochberg’s research has been published in leading journals such as Nature and the Journal of Neuroscience. He received his Sc.B. with Honors in Neural Science from Brown University in 1990. He received his M.D. and Ph.D. from Emory University in 1999, where he was continued an intern in Internal Medicine. He was a resident and Chief Resident in Neurology at MGH/BWH/Harvard Medical School, where he also completed a fellowship in Stroke/Neurocritical Care in 2004.